157 related articles for article (PubMed ID: 32170603)
1. Esculetin Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice Via Modulation of the AKT/ERK/NF-κB and RORγt/IL-17 Pathways.
Lee HC; Liu FC; Tsai CN; Chou AH; Liao CC; Yu HP
Inflammation; 2020 Jun; 43(3):962-974. PubMed ID: 32170603
[TBL] [Abstract][Full Text] [Related]
2. Effects of esculetin on lipopolysaccharide (LPS)-induced acute lung injury via regulation of RhoA/Rho Kinase/NF-кB pathways in vivo and in vitro.
Chen T; Guo Q; Wang H; Zhang H; Wang C; Zhang P; Meng S; Li Y; Ji H; Yan T
Free Radic Res; 2015; 49(12):1459-68. PubMed ID: 26514440
[TBL] [Abstract][Full Text] [Related]
3. Cyanidin-3-O-Glucoside Ameliorates Lipopolysaccharide-Induced Injury Both In Vivo and In Vitro Suppression of NF-κB and MAPK Pathways.
Ma MM; Li Y; Liu XY; Zhu WW; Ren X; Kong GQ; Huang X; Wang LP; Luo LQ; Wang XZ
Inflammation; 2015 Aug; 38(4):1669-82. PubMed ID: 25752620
[TBL] [Abstract][Full Text] [Related]
4. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
5. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
6. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.
Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G
J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201
[TBL] [Abstract][Full Text] [Related]
7. Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice.
Chen X; Yang X; Liu T; Guan M; Feng X; Dong W; Chu X; Liu J; Tian X; Ci X; Li H; Wei J; Deng Y; Deng X; Chi G; Sun Z
Int Immunopharmacol; 2012 Oct; 14(2):209-16. PubMed ID: 22835426
[TBL] [Abstract][Full Text] [Related]
8. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.
Huang Y; Huang L; Zhu G; Pei Z; Zhang W
J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668
[TBL] [Abstract][Full Text] [Related]
9. Suppression of MAPK and NF-κB pathways by limonene contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury.
Chi G; Wei M; Xie X; Soromou LW; Liu F; Zhao S
Inflammation; 2013 Apr; 36(2):501-11. PubMed ID: 23180366
[TBL] [Abstract][Full Text] [Related]
10. Isorhamnetin protects mice from lipopolysaccharide-induced acute lung injury via the inhibition of inflammatory responses.
Chi G; Zhong W; Liu Y; Lu G; Lü H; Wang D; Sun F
Inflamm Res; 2016 Jan; 65(1):33-41. PubMed ID: 26525359
[TBL] [Abstract][Full Text] [Related]
11. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro.
Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z
Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871
[TBL] [Abstract][Full Text] [Related]
12. Barbaloin protects against lipopolysaccharide (LPS)-induced acute lung injury by inhibiting the ROS-mediated PI3K/AKT/NF-κB pathway.
Jiang K; Guo S; Yang C; Yang J; Chen Y; Shaukat A; Zhao G; Wu H; Deng G
Int Immunopharmacol; 2018 Nov; 64():140-150. PubMed ID: 30173054
[TBL] [Abstract][Full Text] [Related]
13. Euphorbia factor L2 alleviates lipopolysaccharide-induced acute lung injury and inflammation in mice through the suppression of NF-κB activation.
Zhang Q; Zhu S; Cheng X; Lu C; Tao W; Zhang Y; William BC; Cao X; Yi S; Liu Y; Zhao Y; Luo Y
Biochem Pharmacol; 2018 Sep; 155():444-454. PubMed ID: 30055150
[TBL] [Abstract][Full Text] [Related]
14. Water extract of Helminthostachys zeylanica attenuates LPS-induced acute lung injury in mice by modulating NF-κB and MAPK pathways.
Liou CJ; Huang YL; Huang WC; Yeh KW; Huang TY; Lin CF
J Ethnopharmacol; 2017 Mar; 199():30-38. PubMed ID: 28119099
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of PKR ameliorates lipopolysaccharide-induced acute lung injury by suppressing NF-κB pathway in mice.
Li Y; Xiao J; Tan Y; Wang J; Zhang Y; Deng X; Luo Y
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):165-172. PubMed ID: 28511573
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice.
San Z; Fu Y; Li W; Zhou E; Li Y; Song X; Wang T; Tian Y; Wei Z; Yao M; Cao Y; Zhang N
Int Immunopharmacol; 2014 Apr; 19(2):342-50. PubMed ID: 24548765
[TBL] [Abstract][Full Text] [Related]
17. Sea Cucumber and Blueberry Extracts Suppress Inflammation and Reduce Acute Lung Injury through the Regulation of NF-κB/MAPK/JNK Signaling Pathway in Lipopolysaccharide-Treated C57BL/6 Mice.
Fagbohun OF; Thilakarathna WPDW; Zhou J; Lehmann C; Jiao G; Rupasinghe HPV
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611791
[TBL] [Abstract][Full Text] [Related]
18. Piperine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via Modulating NF-κB Signaling Pathways.
Lu Y; Liu J; Li H; Gu L
Inflammation; 2016 Feb; 39(1):303-308. PubMed ID: 26410851
[TBL] [Abstract][Full Text] [Related]
19. Erlotinib Protects LPS-Induced Acute Lung Injury in Mice by Inhibiting EGFR/TLR4 Signaling Pathway.
Tao H; Li N; Zhang Z; Mu H; Meng C; Xia H; Fu L; Xu Y; Zhang S
Shock; 2019 Jan; 51(1):131-138. PubMed ID: 29438224
[TBL] [Abstract][Full Text] [Related]
20. Esculetin attenuates lipopolysaccharide (LPS)-induced neuroinflammatory processes and depressive-like behavior in mice.
Zhu L; Nang C; Luo F; Pan H; Zhang K; Liu J; Zhou R; Gao J; Chang X; He H; Qiu Y; Wang J; Long H; Liu Y; Yan T
Physiol Behav; 2016 Sep; 163():184-192. PubMed ID: 27133730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
